Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(4.57)
# 258
Out of 5,154 analysts
76
Total ratings
52%
Success rate
40.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $5.60 | +292.86% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $2.30 | +335.73% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $8.01 | +399.38% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.12 | +792.86% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $15.47 | -61.22% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $5.78 | +124.91% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $25.29 | -20.92% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.90 | +289.83% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $61.88 | +21.20% | 13 | Apr 28, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $36 | $21.20 | +69.81% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.63 | +2,273.79% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.68 | +188.02% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $45.29 | +10.40% | 13 | Nov 26, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $5.60
Upside: +292.86%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $2.30
Upside: +335.73%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $8.01
Upside: +399.38%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.12
Upside: +792.86%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $15.47
Upside: -61.22%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $5.78
Upside: +124.91%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $25.29
Upside: -20.92%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.90
Upside: +289.83%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $61.88
Upside: +21.20%
Day One Biopharmaceuticals
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $21.20
Upside: +69.81%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.63
Upside: +2,273.79%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $8.68
Upside: +188.02%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $45.29
Upside: +10.40%